<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139740">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02150382</url>
  </required_header>
  <id_info>
    <org_study_id>China Medical University</org_study_id>
    <nct_id>NCT02150382</nct_id>
  </id_info>
  <brief_title>China Rural Hypertension Control Project</brief_title>
  <acronym>CRHC</acronym>
  <official_title>Effectiveness of a Standardized Protocol-based Treatment Program on Hypertension Control in Rural China.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Hospital of China Medical University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      China Rural Hypertension Control (CRHC) Project is a cluster randomized trial aims to test
      the effectiveness of a standardized protocol-based treatment program on hypertension control
      in rural China.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>a composite outcome of cardiovascular disease and all-cause mortality</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major cardiovascular diseases</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal and non-fatal stroke</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal and non-fatal myocardial infarction</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalized or treated heart failure</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean systolic and diastolic blood pressure</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of hypertension control</measure>
    <time_frame>up to 2-year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">52800</enrollment>
  <condition>Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All study patients will be recruited from rural areas in Liaoyang County from blood
        pressure screening. Liaoyang County, Liaoning Province is located in Northeast China.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man and women aged 40 years or older.

          -  Mean systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg;
             and/or use of antihypertensive medications.Mean blood pressure is based on three
             measurements at two separate days at least two days apart and within one month.

          -  Permanent residents in the study villages.

          -  Do not plan to emigrate in the next 2 years.

        Exclusion Criteria:

          -  Unable to provide consent.

          -  Treated for malignant tumor and life expectancy&lt;2 years judged by study physician.

          -  Pregnancy, currently trying to become pregnant, or of child-bearing potential and not
             using birth control.

          -  Diagnosted psychiatric patients.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhao Li, PHD</last_name>
    <phone>+86 13504012021</phone>
    <email>2680481161@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 26, 2014</lastchanged_date>
  <firstreceived_date>May 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of China Medical University</investigator_affiliation>
    <investigator_full_name>Yingxian Sun</investigator_full_name>
    <investigator_title>Chief of Department of Cardiology in First Hospital of China Medical University</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>rural</keyword>
  <keyword>China</keyword>
  <keyword>protocol-based treatment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
